Consider time of day to optimize drug delivery; Academic research going unused in clinic;

> "A whole raft of academic nanotechnology research focuses on developing delivery vehicles that will never see reduction to clinical practice," says a critique of the drug delivery ecosystem in the journal Nature Biotechnology. Article

> A study in the Proceedings of the National Academy of Sciences finds that due to our natural "biological clock," the time of day should be considered to optimize drug delivery. Article

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.